Gennao Bio Announces Abstract Accepted for Late-Breaker Poster Presentation at the American Association for Cancer Research (AACR) 2021 Annual Meeting
~ Presentation to highlight the potential of Gennao’s proprietary, non-viral gene monoclonal antibody (GMAB) platform technology to systemically deliver immunostimulatory...